Track Record
Investors
Apposite Capital
- In late 2008 Ithaka was appointed by Apposite Capital to deliver an assignment to provide an opinion on aspects of a novel therapeutic platform as an alternative to antibody-based therapeutics.
- Apposite was considering co-investing in a West Coast US biotech company, Anaphore.
- Subsequent to Ithaka’s assignment, Apposite Capital, 5AM Ventures and Versant Ventures led a $25 million investment in Anaphore in January 2009.
NVM and YFM
- Ithaka regularly undertakes due diligence assignments for venture capital companies. In 2006 and 2007 Ithaka performed a series of business and technical due diligence and performance for NVM Private Equity and YFM venture capital companies leading to investment of around £1M in Gentronix, a University of Manchester spin-out, developing a novel toxicology test for use in pharmaceutical development. A major part of the due diligence review was an assessment of the impact of the proposed investment on sales of the company's first product.